CLINICAL_TRIALS
trial_result
· 2023-11-13
Clinical Trial Update: OPALINE : A Study Of Morbidity And Mortality At 2 Years
Summary
Clinical trial update for OPALINE reports morbidity and mortality outcomes at 2 years in well-differentiated, progressive pancreatic neuroendocrine tumor.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Pancreatic Neuroendocrine Tumor, Well Differentiated and Progressive | Status: COMPLETED | Results posted: 2023-11-13